Implantable cardioverter/defibrillator employing shock delivery timing for preventing induced fibrillation
AssigneePacesetter, Inc.
InventorsMark W. Kroll, Steven W. Badelt, Gabriel A. Mouchawar
Life of this patent
Estimating the term…
Loading patent…
AssigneePacesetter, Inc.
InventorsMark W. Kroll, Steven W. Badelt, Gabriel A. Mouchawar
Estimating the term…
An implantable cardioverter/defibrillator applies a quantity of electrical energy to a heart to terminate an arrhythmia of the heart. The cardioverter/defibrillator employs therapy delivery timing to avoid delivery of the therapy during vulnerable periods of the heart. The cardioverter/defibrillator includes an arrhythmia detector that detects an arrhythmia of the heart, a ventricular activation detector that detects ventricular activations of the heart, and an atrial activation detector that detects atrial activations of the heart. A ventricular timer, resettable by detected ventricular activations, and an atrial timer, resettable by detected atrial activations, keep time responsive to the arrhythmia detector detecting the arrhythmia. A generator applies the quantity of electrical energy to the heart responsive to the arrhythmia detector detecting the arrhythmia, when neither chamber is in its vulnerable period.
An implantable cardioverter/defibrillator which applies a quantity of electrical energy to a heart to terminate a ventricular arrhythmia, the cardioverter/defibrillator comprising:
An implantable cardioverter/defibrillator which applies a quantity of electrical energy to a heart to terminate a ventricular arrhythmia without inducing atrial fibrillation, the cardioverter/defibrillator comprising:
A method of applying a quantity of electrical energy to a heart to terminate a ventricular arrhythmia, the method including the steps of:
Dependencies are inferred from the claim text.